Benjamin L. Barthel

469 total citations
13 papers, 373 citations indexed

About

Benjamin L. Barthel is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Benjamin L. Barthel has authored 13 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pharmacology. Recurrent topics in Benjamin L. Barthel's work include Cancer therapeutics and mechanisms (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Enzyme function and inhibition (2 papers). Benjamin L. Barthel is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Enzyme function and inhibition (2 papers). Benjamin L. Barthel collaborates with scholars based in United States, Australia and Denmark. Benjamin L. Barthel's co-authors include Tad H. Koch, David J. Burkhart, Lori R. Kisley, Bradley S. Barrett, Amy M. Meyer, Alison K. Bauer, David C. Thompson, Lori D. Dwyer‐Nield, Alvin M. Malkinson and J.R. Hagadorn and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Muscle & Nerve.

In The Last Decade

Benjamin L. Barthel

12 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin L. Barthel United States 11 190 67 61 56 54 13 373
Yulia Aleksandrova Russia 12 280 1.5× 85 1.3× 40 0.7× 79 1.4× 80 1.5× 49 502
Haiwei Xu China 12 266 1.4× 127 1.9× 39 0.6× 76 1.4× 42 0.8× 27 518
Feiyue Zhang China 10 190 1.0× 54 0.8× 30 0.5× 23 0.4× 68 1.3× 18 490
Simendra Singh India 9 273 1.4× 67 1.0× 20 0.3× 40 0.7× 84 1.6× 11 474
H. Y. Xu China 11 226 1.2× 39 0.6× 48 0.8× 40 0.7× 27 0.5× 24 410
Shunyu Yao China 13 130 0.7× 36 0.5× 37 0.6× 47 0.8× 29 0.5× 27 531
Chi Meng China 16 255 1.3× 51 0.8× 54 0.9× 158 2.8× 52 1.0× 41 661
Ziwei Miao China 12 246 1.3× 75 1.1× 21 0.3× 34 0.6× 102 1.9× 15 486
Hailin Liu China 15 257 1.4× 100 1.5× 30 0.5× 70 1.3× 95 1.8× 27 720

Countries citing papers authored by Benjamin L. Barthel

Since Specialization
Citations

This map shows the geographic impact of Benjamin L. Barthel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Barthel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Barthel more than expected).

Fields of papers citing papers by Benjamin L. Barthel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin L. Barthel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Barthel. The network helps show where Benjamin L. Barthel may publish in the future.

Co-authorship network of co-authors of Benjamin L. Barthel

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin L. Barthel. A scholar is included among the top collaborators of Benjamin L. Barthel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin L. Barthel. Benjamin L. Barthel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Barthel, Benjamin L., et al.. (2025). Universal Proteomic Signature After Exercise‐Induced Muscle Injury in Muscular Dystrophies. Annals of Clinical and Translational Neurology. 12(5). 998–1011. 1 indexed citations
2.
Barthel, Benjamin L., et al.. (2021). Elevation of fast but not slow troponin I in the circulation of patients with Becker and Duchenne muscular dystrophy. Muscle & Nerve. 64(1). 43–49. 16 indexed citations
3.
Chen, Trevor C., Hung‐Wen Liu, Alan J. Russell, et al.. (2020). Large increases in plasma fast skeletal muscle troponin I after whole-body eccentric exercises. Journal of science and medicine in sport. 23(8). 776–781. 10 indexed citations
4.
Ganesh, Ahil N., Christopher K. McLaughlin, Benjamin L. Barthel, et al.. (2017). Leveraging Colloidal Aggregation for Drug-Rich Nanoparticle Formulations. Molecular Pharmaceutics. 14(6). 1852–1860. 19 indexed citations
5.
Barthel, Benjamin L., et al.. (2016). Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde. Journal of Medicinal Chemistry. 59(5). 2205–2221. 15 indexed citations
6.
7.
Barthel, Benjamin L., et al.. (2012). Synthesis and Biological Characterization of Protease-Activated Prodrugs of Doxazolidine. Journal of Medicinal Chemistry. 55(14). 6595–6607. 29 indexed citations
8.
Barthel, Benjamin L., Zhiyong Zhang, Christopher D. Coldren, et al.. (2009). Preclinical Efficacy of a Carboxylesterase 2-Activated Prodrug of Doxazolidine. Journal of Medicinal Chemistry. 52(23). 7678–7688. 24 indexed citations
9.
Barthel, Benjamin L., Janice L. Hyatt, Carol C. Edwards, et al.. (2008). Identification of Human Intestinal Carboxylesterase as the Primary Enzyme for Activation of a Doxazolidine Carbamate Prodrug. Journal of Medicinal Chemistry. 51(2). 298–304. 29 indexed citations
10.
Koch, Tad H., et al.. (2007). Anthracycline–Formaldehyde Conjugates and Their Targeted Prodrugs. Topics in current chemistry. 283. 141–170. 14 indexed citations
11.
Burkhart, David J., et al.. (2006). Design, Synthesis, and Preliminary Evaluation of Doxazolidine Carbamates as Prodrugs Activated by Carboxylesterases. Journal of Medicinal Chemistry. 49(24). 7002–7012. 40 indexed citations
12.
Barthel, Benjamin L., et al.. (2005). Doxazolidine, a Proposed Active Metabolite of Doxorubicin That Cross-links DNA. Journal of Medicinal Chemistry. 48(24). 7648–7657. 36 indexed citations
13.
Kisley, Lori R., Bradley S. Barrett, Alison K. Bauer, et al.. (2002). Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis.. PubMed. 62(23). 6850–6. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yulia Aleksandrova Breakdown of academic impact, for papers by Haiwei Xu Breakdown of academic impact, for papers by Feiyue Zhang Breakdown of academic impact, for papers by Simendra Singh Breakdown of academic impact, for papers by H. Y. Xu Breakdown of academic impact, for papers by Shunyu Yao Breakdown of academic impact, for papers by Chi Meng Breakdown of academic impact, for papers by Ziwei Miao Breakdown of academic impact, for papers by Hailin Liu
Rankless by CCL
2026